arrow
S

Stewart Goldman

university college london
H指数:66
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients

儿童,年轻成人和老年患者IDH突变型神经胶质瘤的比较分析

2024-07-311
PRE
PNOC005: ONCOLYTIC MEASLES VIRUS FOR THE TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA OR ATYPICAL TERATOID RHABDOID TUMOR
2024-06-180
OAAI
A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA
2024-06-180
OAAI
CLINICAL, RADIOGRAPHIC, HISTOPATHOLOGIC, AND MOLECULAR CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA-AN UPDATE FROM THE INTERNATIONAL AND EUROPEAN SOCIETY FOR PEDIATRIC ONCOLOGY DIPG REGISTRIES (IDIPGR/SIOPE-DIPGR)
2024-06-180
OAAI
The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science
2023-01-0130
OAAI
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma (vol 130, pg 6325, 2020)
2022-06-155
OA
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics
2022-05-2313
OA
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry
2022-05-126
OA
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report

瑞博西尼和依维莫司在新诊断的DIPG和高级别神经胶质瘤患儿中的I期研究: 小儿神经肿瘤学联合会的报告

2022-04-168
OAAI
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)

伏立诺他和异维a酸联合化疗治疗患有胚胎性脑肿瘤的幼儿: 儿科脑肿瘤协会 (PBTC-026) 的报告

2021-12-2218
OA
Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry
2021-10-2011
OA
Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
2021-06-1116
OA
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

司美替尼在无NF1的复发性视神经通路和下丘脑低度神经胶质瘤儿童中的II期试验: 小儿脑肿瘤联盟研究

2021-02-2586
OAAI